underperform recommendation, page-20

  1. 494 Posts.
    From Mac Bank this morning...
    Macquarie 10-Dec-13
    Weekly US testosterone prescription data indicated -5.9% monthly rolling growth which is the lowest growth rate on record.Axiron's market share remains flat, the broker notes. the broker has reduced its target to $2.43 from $2.70 to reflect a likely dividend yield payment in March of around 10%.

    Acrux is looking better value but the broker cannot lift from Underperform while the testosterone trend remains negative.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.7¢
Change
0.000(0.00%)
Mkt cap ! $6.931M
Open High Low Value Volume
1.7¢ 1.7¢ 1.7¢ $9.181K 540.0K

Buyers (Bids)

No. Vol. Price($)
3 401277 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 374874 2
View Market Depth
Last trade - 11.56am 25/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.